Vensana Capital is a pure-play medtech venture capital firm founded by two accomplished specialist VCs who previously led more than a dozen IPO/M&A exits, focusing exclusively on medical devices, life science tools/diagnostics, and clinically oriented data-science/AI rather than broader healthcare categories. The firm has scaled to roughly $1B in assets under management across three oversubscribed funds in just six years and operates Vensana Innovation, a separate medtech innovation engine that systematically originates, incubates, and builds device companies beyond traditional venture capital investing.